5-Hydroxytryptamine (5-HT) causes antinociception via presynaptic 5-HT
3 (5-HT subtype 3) receptors on primary afferent nociceptive neurones
in the spinal cord dorsa I horn. Therefore, ondansetron (a 5-HT3 recep
tor antagonist) may increase the perception of a noxious stimulus or d
ecrease the effects of concurrently administered antinociceptive drugs
. Using a randomized, double blind, crossover study design, we have te
sted this hypothesis in eight healthy volunteers who, on three differe
nt days, received either ondansetron and placebo, ondansetron and alfe
ntanil or placebo and alfentanil. Experimental pain was induced with h
eat, cold, mechanical pressure and electrical stimulation. Ondansetron
alone did not change the response to any of the experimental tests, b
ut alfentanil and the combination ondansetron-alfentanil significantly
changed the response compared with ondansetron alone. There was no di
fference between alfentanil alone and the combination ondansetuon-alfe
ntanil. We conclude that ondansetron does not change the response to p
ressure, heat, cold or electrical nociceptive stimuli or antagonize th
e analgesic effect of alfentanil.